Simulation of COVID-19 symptoms in a genetically engineered mouse model: implications for the long haulers
Authors:
- 22 June 2022
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 478 (1) , 103-119
Abstract
The ongoing pandemic (also known as coronavirus disease-19; COVID-19) by a constantly emerging viral agent commonly referred as the severe acute respiratory syndrome corona virus 2 or SARS-CoV-2 has revealed unique pathological findings from infected human beings, and the postmortem observations. The list of disease symptoms, and postmortem observations is too long to mention; however, SARS-CoV-2 has brought with it a whole new clinical syndrome in “long haulers” including dyspnea, chest pain, tachycardia, brain fog, exercise intolerance, and extreme fatigue. We opine that further improvement in delivering effective treatment, and preventive strategies would be benefited from validated animal disease models. In this context, we designed a study, and show that a genetically engineered mouse expressing the human angiotensin converting enzyme 2; ACE-2 (the receptor used by SARS-CoV-2 agent to enter host cells) represents an excellent investigative resource in simulating important clinical features of the COVID-19. The ACE-2 mouse model (which is susceptible to SARS-CoV-2) when administered with a recombinant SARS-CoV-2 spike protein (SP) intranasally exhibited a profound cytokine storm capable of altering the physiological parameters including significant changes in cardiac function along with multi-organ damage that was further confirmed via histological findings. More importantly, visceral organs from SP treated mice revealed thrombotic blood clots as seen during postmortem examination. Thus, the ACE-2 engineered mouse appears to be a suitable model for studying intimate viral pathogenesis thus paving the way for identification, and characterization of appropriate prophylactics as well as therapeutics for COVID-19 management.Keywords
Funding Information
- Foundation for the National Institutes of Health (HL-74185, HL-139047, DK116591, AR-71789)
This publication has 124 references indexed in Scilit:
- TFAM overexpression reduces pathological cardiac remodelingMolecular and Cellular Biochemistry, 2018
- Reliability and Sensitivity of the TonoLab Rebound Tonometer in Awake Brown Norway RatsInvestigative Ophthalmology & Visual Science, 2009
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- Roles of spike protein in the pathogenesis of SARS coronavirus.2009
- The taming of the cell penetrating domain of the HIV Tat: Myths and realitiesJournal of Controlled Release, 2007
- A newly identified interaction between IVa2 and pVIII proteins during porcine adenovirus type 3 infectionVirology, 2005
- Polyinosinic‐polycytidylic acid‐mediated stimulation of human γδ T cells via CD11c+ dendritic cell‐derived type I interferonsImmunology, 2004
- Transgenic mouse models of hepatitis B virus‐associated hepatocellular carcinomaReviews in Medical Virology, 2003
- Hyperhomocyst(e)inemia induces multiorgan damageHeart and Vessels, 2000
- Biological Transmissibility of Buffalopox VirusJournal of Applied Animal Research, 1996